CV Sciences (CVSI) EBT Margin (2013 - 2026)

CV Sciences has disclosed EBT Margin across 14 years of filings, most recently posting 20.13% for Q1 2026.

• EBT Margin for Q1 2026 came in at 20.13%, down 1730.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.79% (up 551.0% YoY), and the FY2025 annual result was 2.66%, up 1263.0% from the prior year.
• EBT Margin came in at 20.13% for Q1 2026 at CV Sciences, down from 11.43% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 137.56% in Q1 2023 to a low of 105.02% in Q4 2023.
• The 5-year median for EBT Margin is 15.54% (2024), against an average of 17.01%.
• Across the five-year window, EBT Margin surged 17163 bps in 2023 and tumbled 15310 bps in 2024, its largest moves.
• CV Sciences' EBT Margin stood at 61.05% in 2022, then tumbled by 72 bps to 105.02% in 2023, then jumped by 82 bps to 19.05% in 2024, then jumped by 160 bps to 11.43% in 2025, then plunged by 276 bps to 20.13% in 2026.
• The last three EBT Margin figures came in at 20.13% (Q1 2026), 11.43% (Q4 2025), and 11.73% (Q3 2025), per Business Quant data.